| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5453510 | ABBVIE | Neuromuscular blocking agents |
Sep, 2012
(11 years ago) | |
Nimbex Preservative Free is owned by Abbvie.
Nimbex Preservative Free contains Cisatracurium Besylate.
Nimbex Preservative Free has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Nimbex Preservative Free are:
- US5453510
Nimbex Preservative Free was authorised for market use on 15 December, 1995.
Nimbex Preservative Free is available in injectable;injection dosage forms.
Nimbex Preservative Free can be used as method of producing neuromuscular blockade.
The generics of Nimbex Preservative Free are possible to be released after 26 September, 2012.
Drugs and Companies using CISATRACURIUM BESYLATE ingredient
Market Authorisation Date: 15 December, 1995
Treatment: Method of producing neuromuscular blockade
Dosage: INJECTABLE;INJECTION
NIMBEX PRESERVATIVE FREE family patents
